Literature DB >> 26342103

Control of Regulatory T Cell Migration, Function, and Homeostasis.

Daniel J Campbell1.   

Abstract

Foxp3(+) regulatory T cells (Tregs) are essential for preventing autoimmunity and uncontrolled inflammation, and they modulate immune responses during infection and the development of cancer. Accomplishing these tasks requires the widespread distribution of Tregs in both lymphoid and nonlymphoid tissues, and the selective recruitment of Tregs to different tissue sites has emerged as a key checkpoint that controls tissue inflammation in autoimmunity, infection, and cancer development, as well as in the context of allograft acceptance or rejection. Additionally, Tregs are functionally diverse, and it has become clear that some of this diversity segregates with Treg localization to particular tissue sites. In this article, I review the progress in understanding the mechanisms of Treg trafficking and discuss factors controlling their homeostatic maintenance and function in distinct tissue sites.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26342103      PMCID: PMC4778549          DOI: 10.4049/jimmunol.1500801

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  89 in total

1.  Cutting edge: Paracrine, but not autocrine, IL-2 signaling is sustained during early antiviral CD4 T cell response.

Authors:  Meixiao Long; Adam J Adler
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

2.  Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells.

Authors:  Andrea Facciabene; Xiaohui Peng; Ian S Hagemann; Klara Balint; Andrea Barchetti; Li-Ping Wang; Phyllis A Gimotty; C Blake Gilks; Priti Lal; Lin Zhang; George Coukos
Journal:  Nature       Date:  2011-07-13       Impact factor: 49.962

3.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

Review 4.  Regulatory T cells in cancer immunotherapy.

Authors:  Hiroyoshi Nishikawa; Shimon Sakaguchi
Journal:  Curr Opin Immunol       Date:  2014-01-14       Impact factor: 7.486

5.  Modulation of tryptophan catabolism by regulatory T cells.

Authors:  Francesca Fallarino; Ursula Grohmann; Kwang Woo Hwang; Ciriana Orabona; Carmine Vacca; Roberta Bianchi; Maria Laura Belladonna; Maria Cristina Fioretti; Maria-Luisa Alegre; Paolo Puccetti
Journal:  Nat Immunol       Date:  2003-10-26       Impact factor: 25.606

6.  Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response.

Authors:  Nan Zhang; Bernd Schröppel; Girdhari Lal; Claudia Jakubzick; Xia Mao; Dan Chen; Na Yin; Rolf Jessberger; Jordi C Ochando; Yaozhong Ding; Jonathan S Bromberg
Journal:  Immunity       Date:  2009-03-20       Impact factor: 31.745

7.  Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection.

Authors:  Shivani Srivastava; Meghan A Koch; Marion Pepper; Daniel J Campbell
Journal:  J Exp Med       Date:  2014-04-07       Impact factor: 14.307

8.  Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells.

Authors:  Jochen Huehn; Kerstin Siegmund; Joachim C U Lehmann; Christiane Siewert; Uta Haubold; Markus Feuerer; Gudrun F Debes; Joerg Lauber; Oliver Frey; Grzegorz K Przybylski; Uwe Niesner; Maurus de la Rosa; Christian A Schmidt; Rolf Bräuer; Jan Buer; Alexander Scheffold; Alf Hamann
Journal:  J Exp Med       Date:  2004-02-02       Impact factor: 14.307

9.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

10.  Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.

Authors:  Nicholas Arpaia; Clarissa Campbell; Xiying Fan; Stanislav Dikiy; Joris van der Veeken; Paul deRoos; Hui Liu; Justin R Cross; Klaus Pfeffer; Paul J Coffer; Alexander Y Rudensky
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

View more
  79 in total

1.  Cutting Edge: Dynamic Expression of Id3 Defines the Stepwise Differentiation of Tissue-Resident Regulatory T Cells.

Authors:  Jenna M Sullivan; Barbara Höllbacher; Daniel J Campbell
Journal:  J Immunol       Date:  2018-12-05       Impact factor: 5.422

Review 2.  Vive la difference! Self/non-self recognition and the evolution of signatures of identity in arms races with parasites.

Authors:  Claire N Spottiswoode; Robert Busch
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-04-01       Impact factor: 6.237

Review 3.  Cell therapeutic approaches to immunosuppression after clinical kidney transplantation.

Authors:  Christian Morath; Anita Schmitt; Florian Kälble; Martin Zeier; Michael Schmitt; Flavius Sandra-Petrescu; Gerhard Opelz; Peter Terness; Matthias Schaier; Christian Kleist
Journal:  Pediatr Nephrol       Date:  2017-02-23       Impact factor: 3.714

4.  Assessment of immunological profile in ankylosing spondylitis patients following a clinical trial with guluronic acid (G2013), as a new NSAID with immunomodulatory properties.

Authors:  Seyed Shahabeddin Mortazavi-Jahromi; Sepideh Nazeri; Fahimeh Jafarnezhad-Ansariha; Mona Oraei; Abbas Mirshafiey
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

5.  Administration of CD4+CD25highCD127-FoxP3+ Regulatory T Cells for Relapsing-Remitting Multiple Sclerosis: A Phase 1 Study.

Authors:  Kamil Chwojnicki; Dorota Iwaszkiewicz-Grześ; Anna Jankowska; Maciej Zieliński; Paweł Łowiec; Mateusz Gliwiński; Małgorzata Grzywińska; Kamil Kowalczyk; Aleksandra Konarzewska; Paulina Glasner; Justyna Sakowska; Julia Kulczycka; Anna Jaźwińska-Curyłło; Marlena Kubach; Bartosz Karaszewski; Walenty Nyka; Edyta Szurowska; Piotr Trzonkowski
Journal:  BioDrugs       Date:  2021-01-05       Impact factor: 5.807

6.  Dysregulated ICOS+ proinflammatory and suppressive regulatory T cells in patients with rheumatoid arthritis.

Authors:  Hong-Xia Wang; Xia Kang; Shuai Chu; Haixia Li; Xin Li; Xiaofeng Yin; Yu-Rong Qiu; Weinan Lai
Journal:  Exp Ther Med       Date:  2018-08-24       Impact factor: 2.447

7.  Regulatory T cell transfer ameliorates lymphedema and promotes lymphatic vessel function.

Authors:  Epameinondas Gousopoulos; Steven T Proulx; Samia B Bachmann; Jeannette Scholl; Dimitris Dionyssiou; Efterpi Demiri; Cornelia Halin; Lothar C Dieterich; Michael Detmar
Journal:  JCI Insight       Date:  2016-10-06

8.  Notch Ligand Delta-like 4 Promotes Regulatory T Cell Identity in Pulmonary Viral Infection.

Authors:  Hung-An Ting; Matthew A Schaller; Denise E de Almeida Nagata; Andrew J Rasky; Ivan P Maillard; Nicholas W Lukacs
Journal:  J Immunol       Date:  2017-01-11       Impact factor: 5.422

Review 9.  Emerging Opportunities and Challenges in Cancer Immunotherapy.

Authors:  Theresa L Whiteside; Sandra Demaria; Maria E Rodriguez-Ruiz; Hassane M Zarour; Ignacio Melero
Journal:  Clin Cancer Res       Date:  2016-04-15       Impact factor: 12.531

10.  Liraglutide Enhances the Efficacy of Human Mesenchymal Stem Cells in Preserving Islet β-cell Function in Severe Non-obese Diabetic Mice.

Authors:  Li-Rong Li; Xiao-Lei Jia; Hui Hui; Jie Zhang; Ying Liu; Wei-Juan Cui; Qian-Yue Xu; Da-Long Zhu
Journal:  Mol Med       Date:  2016-11-17       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.